Sawai Pharmaceutical | Sustainability Performance
Manufacturer of generic pharmaceutical products.
1929
Japan
1,001 - 5,000 employees
Pharmaceuticals
$1B - 10B in revenue
$25M - 100M in profitability
Sustainability Ranking & Industry Benchmark
#9626
Overall#433
in Japan#230
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Controversy level
- Sawai Group Holdings Co Ltd (formerly Sawai Pharmaceutical), Japanese major generics, has faced sustained Japanese MHLW (Ministry of Health, Labour and Welfare) enforcement scrutiny over the contested 2024 USD 1+ billion Sawai Sumika Pharmaceutical generic pharmaceutical contamination scandal affecting Japanese institutional shareholders amid the broader Japanese generic pharma market normalization pressure.
